tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Actinium Pharmaceuticals Inc

ATNM
Add to Watchlist
1.180USD
+0.010+0.85%
Close 09-23 16:00（ET）
37.02MMarket Cap
LossP/E TTM

Actinium Pharmaceuticals Inc

1.180
+0.010+0.85%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

ATNM Financials

See Actinium Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
37.02M
Dividend TTM
0.00
P/E TTM
-1.57
EPS TTM
-0.75
Revenue
90.00K
Net Profit
-38.24M
ROE
-167.66%
ROA
-41.15%

Actinium Pharmaceuticals Inc Earnings Date

Latest Release
Aug 7, 2026
EPS / Forecast
0.89/-0.22
Revenue / Forecast
35.00M/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
503.03%0.89
65.40%-0.18
10.68%-0.19
55.82%-0.16
41.54%-0.22
-64.33%-0.51
37.29%-0.21
24.12%-0.37
34.87%-0.38
27.62%-0.31
18.61%-0.34
---0.49
---0.58
---0.43
---0.42
---0.94
----
----
----
----
Revenue
--35.00M
--0.00
--0.00
--90.00K
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--81.00K
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-80.69%45.00K
-83.08%45.00K
51.13%940.00K
--23.00K
--233.00K
Net Profit
505.66%27.90M
65.35%-5.52M
10.70%-5.94M
55.64%-5.13M
39.42%-6.88M
-83.83%-15.94M
28.66%-6.65M
12.87%-11.57M
25.22%-11.35M
21.45%-8.67M
12.43%-9.32M
-40.13%-13.28M
-95.46%-15.18M
-115.19%-11.04M
-32.92%-10.65M
-47.50%-9.47M
-54.69%-7.77M
3.59%-5.13M
-25.55%-8.01M
-15.94%-6.42M
Net Margin
--79.72%
----
---37652.22%
---5701.11%
----
----
----
----
----
----
---11511.11%
----
----
----
----
---2171.84%
----
----
----
----
Gross Margin
--100.00%
----
--100.00%
--100.00%
----
----
----
----
----
----
--100.00%
----
----
----
----
--100.00%
----
----
----
----
Debt to assets ratio
-50.96%0.01%
-32.84%0.02%
-18.30%0.02%
-17.35%0.02%
-8.73%0.03%
-17.26%0.03%
-29.38%0.03%
2400.89%0.03%
1277.23%0.03%
977.89%0.03%
952.29%0.04%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
Income Statement
Revenue
--35.00M
--0.00
--0.00
--90.00K
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--81.00K
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-80.69%45.00K
-83.08%45.00K
51.13%940.00K
--23.00K
--233.00K
Operating profit
467.39%27.57M
64.52%-5.90M
14.54%-6.41M
54.83%-5.69M
39.58%-7.50M
-73.37%-16.64M
27.44%-7.50M
12.19%-12.60M
20.61%-12.42M
17.15%-9.60M
8.40%-10.34M
-46.45%-14.35M
-99.26%-15.64M
-124.32%-11.58M
-40.30%-11.29M
-51.48%-9.80M
-54.68%-7.85M
3.87%-5.16M
-25.07%-8.05M
-15.25%-6.47M
Net Profit
505.66%27.90M
65.35%-5.52M
10.70%-5.94M
55.64%-5.13M
39.42%-6.88M
-83.83%-15.94M
28.66%-6.65M
12.87%-11.57M
25.22%-11.35M
21.45%-8.67M
12.43%-9.32M
-40.13%-13.28M
-95.46%-15.18M
-115.19%-11.04M
-32.92%-10.65M
-47.50%-9.47M
-54.69%-7.77M
3.59%-5.13M
-25.55%-8.01M
-15.94%-6.42M
Balance Sheet
Current assets
-38.16%37.74M
-34.90%43.26M
-33.72%49.38M
-31.63%54.37M
-29.91%61.03M
-22.16%66.46M
-4.80%74.51M
-7.10%79.52M
-8.86%87.07M
-13.37%85.37M
-29.46%78.26M
-24.53%85.60M
-19.24%95.54M
33.07%98.55M
39.11%110.94M
36.23%113.42M
42.23%118.30M
0.41%74.05M
22.83%79.75M
69.30%83.26M
Total current liabilities
11.38%9.26M
3.36%7.35M
-2.20%7.97M
-11.88%6.83M
-14.54%8.31M
-11.83%7.11M
-4.07%8.15M
-10.57%7.75M
6.31%9.73M
2.54%8.06M
-20.08%8.49M
3.86%8.67M
45.67%9.15M
37.41%7.86M
55.38%10.63M
99.28%8.35M
62.20%6.28M
37.44%5.72M
43.49%6.84M
-10.47%4.19M
Total assets
-36.28%40.16M
-33.81%45.44M
-32.67%51.77M
-31.62%56.15M
-29.87%63.02M
-22.30%68.65M
-5.58%76.90M
-7.68%82.11M
-9.28%89.86M
-13.40%88.35M
-28.68%81.44M
-23.86%88.94M
-18.68%99.05M
36.83%102.03M
42.05%114.19M
38.28%116.82M
44.22%121.80M
-0.71%74.56M
21.07%80.39M
67.20%84.48M
Total liabilities
-77.60%9.86M
0.42%43.13M
-0.45%43.94M
-3.51%42.37M
-4.39%44.00M
-3.47%42.95M
-2.05%44.14M
-3.21%43.91M
0.11%46.03M
-0.72%44.49M
-5.54%45.07M
-0.44%45.36M
5.40%45.97M
682.85%44.82M
597.22%47.71M
986.34%45.56M
1002.88%43.62M
31.28%5.72M
34.76%6.84M
-17.76%4.19M
Total equity
59.38%30.30M
-91.03%2.30M
-76.09%7.83M
-63.92%13.78M
-56.63%19.01M
-41.41%25.69M
-9.95%32.76M
-12.33%38.21M
-17.41%43.84M
-23.34%43.86M
-45.28%36.38M
-38.84%43.58M
-32.11%53.08M
-16.89%57.21M
-9.61%66.48M
-11.25%71.25M
-2.88%78.18M
-2.68%68.84M
19.94%73.55M
76.73%80.28M
Cash Flow Statement
Net operating income
3.95%-5.18M
22.50%-5.87M
8.03%-5.29M
47.18%-6.33M
32.36%-5.39M
-2.71%-7.57M
23.22%-5.75M
-7.64%-11.97M
41.57%-7.97M
51.09%-7.37M
3.70%-7.49M
-94.66%-11.13M
-148.87%-13.64M
-160.80%-15.08M
-53.96%-7.78M
-2.27%-5.71M
709.03%27.92M
-2.46%-5.78M
19.27%-5.05M
-11.89%-5.59M
Net investment
---478.00K
---2.00K
---104.00K
--0.00
--0.00
100.00%0.00
--0.00
100.00%0.00
100.00%0.00
85.53%-11.00K
100.00%0.00
58.90%-30.00K
82.59%-47.00K
-985.71%-76.00K
---16.00K
-7.35%-73.00K
-342.62%-270.00K
-75.00%-7.00K
100.00%0.00
-750.00%-68.00K
Net financing
33.33%-2.00K
-50.00%-3.00K
0.00%-3.00K
-104.54%-209.00K
-100.03%-3.00K
-100.01%-2.00K
-100.25%-3.00K
60.91%4.60M
-0.94%9.95M
1817.92%14.77M
-75.64%1.19M
81.59%2.86M
-39.70%10.05M
3600.00%770.00K
510.86%4.89M
-72.73%1.57M
16.49%16.66M
-100.15%-22.00K
-96.33%801.00K
2611.30%5.78M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Actinium Pharmaceuticals Inc?

According to Actinium Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 90.00K, with a year-on-year change of 90.00K.

What are the current assets of Actinium Pharmaceuticals Inc?

According to Actinium Pharmaceuticals Inc's FY2025 earnings report, its current assets were 49.38M, with a year-on-year change of -33.72.

What are the total assets of Actinium Pharmaceuticals Inc?

According to Actinium Pharmaceuticals Inc's FY2025 earnings report, its total assets of Actinium Pharmaceuticals Inc were 51.77M, with a year-on-year change of -32.67.

What are the total liabilities of Actinium Pharmaceuticals Inc?

According to Actinium Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Actinium Pharmaceuticals Inc were 43.94M, with a year-on-year change of -0.45.

What is the total equity of Actinium Pharmaceuticals Inc?

According to Actinium Pharmaceuticals Inc's FY2025 earnings report, its total equity of Actinium Pharmaceuticals Inc was 7.83M, with a year-on-year change of -76.09.

What is the net operating income of Actinium Pharmaceuticals Inc?

According to Actinium Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Actinium Pharmaceuticals Inc was -36.25M, with a year-on-year change of 13.95.

What is the net investment of Actinium Pharmaceuticals Inc?

According to Actinium Pharmaceuticals Inc's FY2025 earnings report, its net investment of Actinium Pharmaceuticals Inc was -104.00K, with a year-on-year change of -845.45.

What is the net financing of Actinium Pharmaceuticals Inc?

According to Actinium Pharmaceuticals Inc's FY2025 earnings report, its net financing of Actinium Pharmaceuticals Inc was -217.00K, with a year-on-year change of -100.74.

What is the Earnings Per Share (EPS) of Actinium Pharmaceuticals Inc?

According to Actinium Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.09, with a year-on-year change of 14.59.

What is the net income of Actinium Pharmaceuticals Inc?

According to Actinium Pharmaceuticals Inc's FY2025 earnings report, its net income was -33.89M, with a year-on-year change of 11.39.

What is the debt-to-asset ratio of Actinium Pharmaceuticals Inc?

According to Actinium Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 0.02, with a year-on-year change of -18.30.

What is the Return on Equity (ROE) of Actinium Pharmaceuticals Inc?

According to Actinium Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -166.96, with a year-on-year change of -50.92.

What is the Return on Assets (ROA) of Actinium Pharmaceuticals Inc?

According to Actinium Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -52.67, with a year-on-year change of -9.04.

What is the operating profit of Actinium Pharmaceuticals Inc?

According to Actinium Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -36.25M, with a year-on-year change of 13.95.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy